Insulin-induced remission in new-onset NOD mice is maintained by the PD-1–PD-L1 pathway

The past decade has seen a significant increase in the number of potentially tolerogenic therapies for treatment of new-onset diabetes. However, most treatments are antigen nonspecific, and the mechanism for the maintenance of long-term tolerance remains unclear. In this study, we developed an antig...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Fife, Brian T., Guleria, Indira, Gubbels Bupp, Melanie, Eagar, Todd N., Tang, Qizhi, Bour-Jordan, Helene, Yagita, Hideo, Azuma, Miyuki, Sayegh, Mohamed H., Bluestone, Jeffrey A.
Formato: Artigo
Idioma:Inglês
Publicado em: The Rockefeller University Press 2006
Assuntos:
Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2118162/
https://ncbi.nlm.nih.gov/pubmed/17116737
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1084/jem.20061577
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados